CDEK
← All organizations

Teva

For profitContributed to NMEWebsite ↗

Also known as: Cephalon, Inc., a wholly-owned subsidiary of Teva Pharmaceutical Industries Ltd. | Claudio Brandi, MD | Gamida Cell -Teva Joint Venture Ltd. | GATE PHARMS | GENERICS | IVAX SUB TEVA PHARMS | Merckle GmbH, Teva Ratiopharm | Santiago Bertone, MD | TEVA | TEVA BRANDED PHARM | Teva Branded Pharmaceutical Products R&D, Inc. | Teva Branded Pharmaceutical Products, R&D Inc. | Teva Branded Pharmaceutical Products R&D LLC | Teva Branded Pharmaceuticals Products R&D, Inc. | Teva Canada | Teva GBP | Teva GCO | Teva Global Respiratory Research | Teva GTC | Teva Nederland BV | Teva Neuroscience Canada | Teva Neuroscience, Inc. | TEVA PARENTERAL | TEVA PHARM | Teva Pharma | Teva Pharmaceutical Industries | Teva Pharmaceutical Industries, Ltd. | Teva Pharmaceuticals Development, Inc. | TEVA PHARMACEUTICALS DEVELOPMENT INC | Teva Pharmaceuticals Europe | Teva Pharmaceuticals, Inc. | TEVA PHARMACEUTICALS, INC. | Teva Pharmaceuticals Industries LTD | Teva Pharmaceuticals USA | TEVA PHARMACEUTICALS USA, INC. | TEVA Pharmachemie | Teva Pharma GmbH | TEVA PHARMS | TEVA PHARMS INC | TEVA PHARMS INTL | TEVA PHARMS USA | TEVA PHARMS USA INC | Teva Respiratory, LLC | TEVA RESPIRATORY LLC | Teva Respiratory R&D | Teva (v1) | Teva (v2) | TEVA WOMENS | Teva Women's Health | Teva Women's Health, Inc. | Teva Women's Health Research | UAB Teva Baltics | US GENERICS, STERILES | WATSON LABS TEVA

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Jul 1, 1994

First marketed drug

Oct 12, 1948

First NDA

Mar 7, 1951

Last known activity

Apr 23, 2026

Timeline

1900s

  1. Jan 1, 1901

    Teva— Founded

1960s

  1. Jan 1, 1968

    Assia-Zori— Acquired

1980s

  1. Jan 1, 1980

    Ikapharm— Acquired

  2. Jan 1, 1980

    Plantex, Ltd— Acquired

  3. Jan 1, 1985

    Lemmon Pharmacal— Acquired

  4. Jan 1, 1988

    Abic— Acquired

1990s

  1. Jan 1, 1992

    GRY-Pharm— Acquired

  2. Jan 1, 1992

    TAG Pharmaceuticals— Acquired

  3. Jan 1, 1993

    Prosintex— Acquired

  4. Jan 1, 1995

    Biogal— Acquired

  5. Jan 1, 1996

    Biocraft— Acquired

  6. Dec 20, 1996

    glatiramer acetate— NDA Organization

  7. Dec 1, 1998

    Pharmachemie Bv— Acquired

  8. Aug 10, 1999

    Copley Pharmaceuticals— Acquired

2000s

  1. Aug 1, 2003

    Regent Drugs Limited— Acquired

  2. Jan 22, 2004

    Gensia Sicor— Acquired

  3. Jan 1, 2006

    Ivax— Acquired

  4. Jan 1, 2007

    Med Ilac— Acquired

  5. Jan 22, 2008

    CoGenesys— Acquired

  6. Jul 23, 2008

    Bentley Pharmaceuticals— Acquired

  7. Jan 6, 2009

    Barr Laboratories— Acquired

  8. Apr 3, 2009

    ibandronate— Marketing Organization

2010s

  1. Aug 10, 2010

    Ratiopharm— Acquired

  2. Jan 5, 2011

    Theramex— Acquired

  3. Jan 26, 2011

    Corporacion Infarmasa— Acquired

  4. Jul 25, 2011

    Taiyo— Acquired

  5. Oct 14, 2011

    Cephalon— Acquired

  6. Jan 1, 2013

    MicroDose— Acquired

  7. Jan 1, 2014

    Labrys Biologics, Inc.— Acquired

  8. Jan 1, 2015

    Gecko Health Innovations, Inc— Acquired

  9. Jan 1, 2015

    Representaciones e Investigaciones Medicas— Acquired

  10. May 5, 2015

    Auspex Pharmaceuticals— Acquired

2020s

  1. Apr 28, 2023

    risperidone— NDA Secondary Org

Drugs by trial phase (263 distinct, 725 trials)

Other trials (1 own, 0 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (541)

Subsidiaries (29 direct, 53 total across the full acquisition tree)

Recent trials (50)

Details

Founded
Petah Tiqva, IL Jan 1, 1901
First NDA
Mar 7, 1951
Last known activity
Apr 23, 2026

Designations held

  • Orphan drug
  • Fast track
  • Priority review
  • Accelerated approval

Notes

https://www.tevausa.com/History.aspx